These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16127675)

  • 41. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.
    Okunade AA; Suraratdecha C
    Soc Sci Med; 2006 Jul; 63(1):225-38. PubMed ID: 16459005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community drug expenditure and recent cost containment measures.
    Walshe V; Kenneally M
    Ir Med J; 2013 Feb; 106(2):44-6. PubMed ID: 23472384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia.
    Grootendorst P; Stewart D
    Health Econ; 2006 Jul; 15(7):735-42. PubMed ID: 16498702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The demand for physician services. Evidence from a natural experiment.
    Cockx B; Brasseur C
    J Health Econ; 2003 Nov; 22(6):881-913. PubMed ID: 14604552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure.
    Hughes D; McGuire A
    Health Econ; 1995; 4(3):213-20. PubMed ID: 7550771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demand analysis of tobacco consumption in Malaysia.
    Ross H; Al-Sadat NA
    Nicotine Tob Res; 2007 Nov; 9(11):1163-9. PubMed ID: 17978990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco taxes and regressivity.
    Gospodinov N; Irvine I
    J Health Econ; 2009 Mar; 28(2):375-84. PubMed ID: 19091432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index.
    Mullins CD; Palumbo FB; Saba M
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):377-84. PubMed ID: 17567239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dental insurance, income and the use of dental care in Canada.
    Bhatti T; Rana Z; Grootendorst P
    J Can Dent Assoc; 2007 Feb; 73(1):57. PubMed ID: 17295945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The price sensitivity of Medicare beneficiaries: a regression discontinuity approach.
    Buchmueller TC; Grazier K; Hirth RA; Okeke EN
    Health Econ; 2013 Jan; 22(1):35-51. PubMed ID: 22278904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of cost sharing on the demand for prescription drugs in Belgium.
    van Doorslaer E
    Acta Hosp; 1984; 24(3):69-81. PubMed ID: 10268808
    [No Abstract]   [Full Text] [Related]  

  • 54. The differences in characteristics between health-care users and non-users: implication for introducing community-based health insurance in Burkina Faso.
    Dong H; Gbangou A; De Allegri M; Pokhrel S; Sauerborn R
    Eur J Health Econ; 2008 Feb; 9(1):41-50. PubMed ID: 17186201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Price indexes for pharmaceuticals used by the elderly.
    Thomas J; Schondelmeyer S
    Health Care Financ Rev; 1992; 14(1):91-105. PubMed ID: 10124442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should the US allow prescription drug reimports from Canada?
    Pecorino P
    J Health Econ; 2002 Jul; 21(4):699-708. PubMed ID: 12146598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Data briefing. Charges.
    Appleby J
    Health Serv J; 1999 Oct; 109(5675):32. PubMed ID: 10662321
    [No Abstract]   [Full Text] [Related]  

  • 58. The drivers of overspending on prescription drugs in Quebec.
    Smolina K; Morgan S
    Healthc Policy; 2014 Nov; 10(2):19-26. PubMed ID: 25617512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opinion: price controls on prescription drugs.
    Franks B
    N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
    [No Abstract]   [Full Text] [Related]  

  • 60. Price and the demand for nongroup health insurance.
    Auerbach D; Ohri S
    Inquiry; 2006; 43(2):122-34. PubMed ID: 17004642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.